Stay updated on NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Sign up to get notified when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.
Latest website image capture
Clouds background image

Latest updates to the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    Page now shows a newer date and updated study-status entry, replacing an older date; overall meaning shifts toward current status information without affecting core transactional elements.
    Difference
    0.6%
    Check dated 2025-10-12T14:25:29.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    - Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    9%
    Check dated 2025-10-05T10:05:55.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.2%
    Check dated 2025-09-28T03:13:00.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    - Updated revision from v3.0.1 to v3.0.2 and removed the 'Back to Top' element.
    Difference
    0.5%
    Check dated 2025-09-13T17:37:25.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or important information.
    Difference
    0.5%
    Check dated 2025-09-06T15:06:16.000Z thumbnail image
  8. Check
    62 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location details, while removing specific location terms and listed countries. This indicates a shift towards a more streamlined presentation of study status information.
    Difference
    55%
    Check dated 2025-08-30T11:49:29.000Z thumbnail image

Stay in the know with updates to NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Enter your email address, and we'll notify you when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.